Complete guide
Weight-loss injections: lose fat, not muscle
Semaglutide and tirzepatide produced weight losses of 15% to over 20% in around 70 weeks. Part of that loss is lean mass, and one year after stopping, participants regained about two thirds of the weight. Resistance training and adequate protein are the two support measures the literature converges on.
Mounjaro and Zepbound are brands of tirzepatide; Ozempic and Wegovy are brands of semaglutide; Saxenda and Victoza are brands of liraglutide. The brands belong to their respective manufacturers and are named here only to identify the active ingredients studied.
What Letz does
Strength in your routine
Your plan prioritises strength sessions within the days you have available, to help preserve lean mass.
Protein with a small appetite
A daily protein reference, with smaller meal options for days when appetite is low.
Hydration in view
Log your water and follow the daily hydration reference on the home screen.
A coach who knows the phase
It talks with that context, never comments on doses and points you to care when symptoms are strong.
What Letz never does
Letz does not prescribe, recommend, adjust or suggest stopping any medication. Treatment decisions belong to your doctor. Strong symptoms are a reason to seek care.
- Recommend or advise against any medication
- Suggest a dose, a dose adjustment or a switch of active ingredient
- Give an opinion on when or whether to stop treatment
- Present injury risk as an individual probability
- Treat a body-composition estimate as a measurement
Rules and studies
- GLP-1: Lean Mass and Regain After Discontinuation
Trials observed substantial weight loss, with some reduction in lean mass. In the STEP 1 extension, weight regain followed withdrawal of both semaglutide and lifestyle support. Supervised exercise was studied with liraglutide.
- Separate semaglutide and tirzepatide trials reported average losses of about 15% to over 20% over 68–72 weeks, depending on dose and protocol; these are not individual forecasts.
- In the exploratory STEP 1 extension, one year after semaglutide and lifestyle support were withdrawn, the group regained an average of about two-thirds of the weight lost.
- In the liraglutide trial, supervised exercise combined with medication improved maintenance and body composition; this does not automatically validate any exercise program or another medication.
- Reviews discuss resistance training and protein as support for preserving lean mass; they do not guarantee complete preservation or provide instructions to change treatment.
- Nutritional Support During GLP-1 Treatment
Monitoring should prioritize symptoms, nutritional adequacy, protein, resistance training, and preserving lean mass and function.
- Adequate protein, resistance training, and close monitoring of gastrointestinal symptoms are top priorities during care.
- Appetite suppression can lead to insufficient intake of essential nutrients.
- Planning for post-treatment maintenance is an integral part of care.
- Protein of 1.2 to 1.6 g/kg during weight loss (on adjusted body weight in obesity), never below 60 to 75 g per day.
- Strength training 2 to 3 times a week and at least 150 minutes of aerobic activity; more than 2 liters of fluids a day.
All posts
Mounjaro and lean mass: how much muscle is actually lost?
Part of the weight lost with tirzepatide and semaglutide is lean mass. What trials measured and two supportive strategies backed by evidence.
3 min readWeight Regain After Stopping the Injection (GLP-1): What the Semaglutide Study Showed
In the STEP 1 extension, semaglutide and lifestyle support ended together. Learn about average weight regain and the limits of this comparison.
3 min readHow Much Protein to Eat on a Weight-Loss Injection
Protein during treatment: study limits with training, individualized targets, and navigating reduced appetite.
3 min readResistance Training on GLP-1 Injections: The Workout That Preserves Lean Mass
Resistance training supports GLP-1 treatment effectively. Learn about volume, frequency, and adjusting workouts when energy drops.
3 min readMounjaro, Ozempic, Wegovy, and Saxenda: What the Clinical Trials Measured
Which active ingredient is in each brand and what weight loss phase 3 trials reported. A reference guide with no medical recommendations.
2 min readLosing Fat or Muscle? How to Tell Without a DEXA Scan
The scale cannot separate fat from lean mass. Learn which markers to track at home, what they actually show, and where the readings fall short.
2 min readHow to Eat With Low Appetite During Treatment
Strategies for eating enough and maintaining variety with a reduced appetite, respecting individual tolerance and clinical monitoring.
2 min readWhat Letz Does—and Will Never Do—Alongside an Injection (GLP-1)
The explicit boundary: training, protein, and routine support around a prescribed treatment. Nothing about dosing, indication, or discontinuation.
2 min readFrequently asked questions
How much of the weight lost on Mounjaro is muscle?
There is no single percentage of muscle lost. Body composition analyses measure lean mass, which also includes water and other tissues. Adequate protein and resistance training are supportive strategies, but they do not guarantee the same outcome for everyone.
Can lean mass loss be completely prevented?
There is no evidence that lean mass loss can be eliminated entirely during a calorie deficit of this magnitude. What the scientific literature supports is minimizing it through high protein intake and resistance training maintained throughout treatment.
Do I need to lift heavy or is walking enough?
Walking does not replace resistance training for preserving lean mass: the stimulus that signals the maintenance of lean tissue is mechanical and specific. Aerobic activity offers other health benefits, but it does not serve this function.
Does everyone regain the weight after stopping?
That conclusion cannot be drawn. About two-thirds is a group average from the STEP 1 extension, where semaglutide and lifestyle support were withdrawn together. Individual variation exists, and this number is not a forecast for all medications.
Can you maintain the weight loss without the medication?
Some people maintain part or all of the lost weight, but habits do not guarantee that outcome. The decision regarding continued treatment and the maintenance plan should be discussed with your healthcare team.
When should I start preparing to stop?
A maintenance plan can be discussed from the very beginning, without assuming that the medication will be discontinued. Habit formation takes varying amounts of time; when and whether to stop are clinical decisions.
How much protein per day when using Ozempic or Mounjaro?
There is no universal floor above 1.6 g/kg for Ozempic or Mounjaro users. Your healthcare team should establish the target and reference weight based on clinical condition, total energy, and tolerance. A range studied in healthy adults performing intense training cannot be automatically applied to all patients.
Do I need to take whey protein?
Not necessarily. What the evidence supports is daily total and distribution, not a specific source. Supplements can make things easier when tolerance to solid foods is reduced, but they are not mandatory.
What if I cannot eat anywhere near that amount?
Persistently very low intake is a clinical issue, not a matter of discipline, and should be discussed with the provider overseeing your treatment. Scientific society guidelines treat nutritional adequacy and gastrointestinal symptoms as a follow-up priority.
How many times per week should I train during treatment?
Two weekly strengthening sessions serve as a general baseline for physical activity, rather than a requirement to hit each muscle twice. During treatment, work with your healthcare team to find a frequency aligned with your energy, symptoms, and recovery; overall volume and consistency matter just as much.
The studies behind this
- Wilding et al., New England Journal of Medicine, 2021 DOI 10.1056/NEJMoa2032183
- Wilding et al., Diabetes, Obesity and Metabolism, 2022 DOI 10.1111/dom.14725
- Jastreboff et al., New England Journal of Medicine, 2022 DOI 10.1056/NEJMoa2206038
- Lundgren et al., New England Journal of Medicine, 2021 DOI 10.1056/NEJMoa2028198
- Neeland et al., Diabetes, Obesity and Metabolism, 2024 DOI 10.1111/dom.15728
- Mozaffarian et al., American Journal of Clinical Nutrition, 2025 DOI 10.1016/j.ajcnut.2025.04.023
- Almandoz et al., Obesity, 2024 DOI 10.1002/oby.24067
- Sievenpiper et al., Obesity Pillars, 2026 DOI 10.1016/j.obpill.2025.100228
Support through treatment
In injection mode, your plan prioritises strength sessions within your available days, protein gets a daily floor across smaller meals and the coach knows which phase you are in.
Get started